CLBT
Cellebrite DI
11.20$
+1.2%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +50.2% | -77.1% | +44.5% | +187.0% | +58.4% | -68.4% | +56.1% | +2.1% | +147.1% | -75.8% | -11.5% | – | |
| – | +9.9% | +2.5% | -3.9% | +1.8% | +4.1% | -3.6% | -1.5% | +4.3% | +45.8% | +77.7% | +27.3% | – | |
| – | +3.7% | +12.6% | +15.1% | +38.1% | +2.4% | -5.3% | +0.4% | +73.8% | -21.6% | +19.9% | +6.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +272.4% | -122.4% | – | – | +244.3% | -111.5% | – | -140.2% | – | -120.5% | – | – | |
| – | +357.2% | -57.1% | +10.9% | -22.6% | +137.2% | -45.8% | +54.3% | -7.9% | +19.1% | -23.1% | +0.9% | – | |
| – | – | -2,681.3% | -59.2% | -43.9% | -14.6% | +693.2% | – | +57.2% | -485.8% | -94.5% | +1.3% | – | |
| – | – | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | -48.6% | +11.9% | -34.4% | +66.3% | +21.7% | -46.2% | +281.9% | -61.9% | +31.5% | -49.3% | +2.8% | – | |
| – | +97.5% | -227.9% | – | – | +88.2% | -282.9% | – | +15.1% | -253.6% | – | -18.1% | – | |
| – | +38.4% | -79.6% | +53.5% | +227.5% | +54.8% | -69.9% | +56.3% | +3.4% | +161.3% | -78.5% | -13.8% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.